<div id=toc></div>

# Table of Contents

- [q-bio.GN](#q-bio.GN) [Total: 1]
- [q-bio.QM](#q-bio.QM) [Total: 4]
- [cs.CV](#cs.CV) [Total: 2]
- [cs.LG](#cs.LG) [Total: 1]


<div id='q-bio.GN'></div>

# q-bio.GN [[Back]](#toc)

### [1] [FASTR: Reimagining FASTQ via Compact Image-inspired Representation](https://arxiv.org/abs/2601.17184)
*Adrian Tkachenko,Sepehr Salem,Ayotomiwa Ezekiel Adeniyi,Zulal Bingol,Mohammed Nayeem Uddin,Akshat Prasanna,Alexander Zelikovsky,Serghei Mangul,Can Alkan,Mohammed Alser*

Main category: q-bio.GN

TL;DR: FASTR是一种新的无损计算原生格式，将核苷酸和碱基质量分数编码为单个8位值，相比FASTQ减少至少2倍文件大小，同时保持完全可逆且可直接用于下游分析。


<details>
  <summary>Details</summary>
Motivation: 高通量测序产生海量数据，FASTQ格式存储效率低下（每个碱基和质量分数各占1字节），导致存储、传输和分析瓶颈。现有压缩工具虽然能缓解部分问题，但通常引入昂贵的解压缩成本或复杂的依赖问题。

Method: FASTR将每个核苷酸与其碱基质量分数一起编码为单个8位值，创建了一种无损、计算原生的格式。提供了高度并行的软件生态系统用于FASTQ-FASTR转换，并与现有工具（如minimap2）集成，只需最小接口更改且无性能开销。

Result: FASTR将文件大小减少至少2倍，在Illumina、HiFi和ONT reads上，对FASTR应用通用压缩工具相比FASTQ分别获得2.47、3.64和4.8倍更快的压缩速度，以及2.34、1.96、1.75倍更快的解压缩速度。FASTR可直接作为数值向量或类图像表示使用，适合机器学习应用。

Conclusion: FASTR通过消除解压缩成本和减少数据移动，为可扩展的基因组学分析和实时测序工作流程奠定了基础，是FASTQ格式的高效替代方案。

Abstract: Motivation: High-throughput sequencing (HTS) enables population-scale genomics but generates massive datasets, creating bottlenecks in storage, transfer, and analysis. FASTQ, the standard format for over two decades, stores one byte per base and one byte per quality score, leading to inefficient I/O, high storage costs, and redundancy. Existing compression tools can mitigate some issues, but often introduce costly decompression or complex dependency issues. Results: We introduce FASTR, a lossless, computation-native successor to FASTQ that encodes each nucleotide together with its base quality score into a single 8-bit value. FASTR reduces file size by at least 2x while remaining fully reversible and directly usable for downstream analyses. Applying general-purpose compression tools on FASTR consistently yields higher compression ratios, 2.47, 3.64, and 4.8x faster compression, and 2.34, 1.96, 1.75x faster decompression than on FASTQ across Illumina, HiFi, and ONT reads. FASTR is machine-learning-ready, allowing reads to be consumed directly as numerical vectors or image-like representations. We provide a highly parallel software ecosystem for FASTQ-FASTR conversion and show that FASTR integrates with existing tools, such as minimap2, with minimal interface changes and no performance overhead. By eliminating decompression costs and reducing data movement, FASTR lays the foundation for scalable genomics analyses and real-time sequencing workflows. Availability and Implementation: https://github.com/ALSER-Lab/FASTR

</details>


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [2] [Domain-Aware Geometric Multimodal Learning for Multi-Domain Protein-Ligand Affinity Prediction](https://arxiv.org/abs/2601.17102)
*Shuo Zhang,Jian K. Liu*

Main category: q-bio.QM

TL;DR: DAGML是一个用于多域蛋白质-配体结合亲和力预测的层次化几何深度学习框架，通过显式建模域模块化来提升预测精度。


<details>
  <summary>Details</summary>
Motivation: 当前几何深度学习方法通常将蛋白质视为单一图结构，无法捕捉多域蛋白质中域间动态和柔性连接子对分子识别的关键影响，这限制了多域蛋白质-配体结合亲和力的准确预测。

Method: DAGML结合预训练蛋白质语言模型和新型域感知几何编码器，区分域内和域间特征；同时使用以基序为中心的配体编码器捕捉药效兼容性；并构建了专门的多域亲和力基准数据集，按结合拓扑分类复合物。

Result: 实验表明DAGML相比强基线方法，MSE降低21%，Pearson相关系数达到0.726；消融研究证实显式建模域界面是性能提升的主要驱动力，特别是对于在结构单元间裂隙结合的配体。

Conclusion: DAGML通过层次化建模域模块化，显著提升了多域蛋白质-配体结合亲和力预测的准确性，为药物发现提供了更有效的计算工具。

Abstract: The accurate prediction of protein-ligand binding affinity is important for drug discovery yet remains challenging for multi-domain proteins, where inter-domain dynamics and flexible linkers govern molecular recognition. Current geometric deep learning methods typically treat proteins as monolithic graphs, failing to capture the distinct geometric and energetic signals at domain interfaces. To address this, we introduce DAGML (Domain-Aware Geometric Multimodal Learning), a hierarchical framework that explicitly models domain modularity. DAGML integrates a pre-trained protein language model with a novel domain-aware geometric encoder to distinguish intra- and inter-domain features, while a motif-centric ligand encoder captures pharmacophoric compatibility. We further curate a specialized multi-domain affinity benchmark, classifying complexes by binding topology (e.g., interface vs linker binders). Extensive experiments demonstrate that DAGML achieves a 21% reduction in MSE and a Pearson correlation of 0.726 compared to strong baselines. Ablation studies reveal that explicit modeling of domain interfaces is the primary driver of this improvement, particularly for ligands binding in the clefts between structural units. The code is available at https://github.com/jiankliu/DAGML.

</details>


### [3] [GenAI-Net: A Generative AI Framework for Automated Biomolecular Network Design](https://arxiv.org/abs/2601.17582)
*Maurice Filo,Nicolò Rossi,Zhou Fang,Mustafa Khammash*

Main category: q-bio.QM

TL;DR: GenAI-Net是一个生成式AI框架，用于自动化设计实现特定动态功能的化学反应网络，通过代理提出反应并进行模拟评估。


<details>
  <summary>Details</summary>
Motivation: 设计实现特定动态功能的化学反应网络目前主要依赖人工，需要从庞大的拓扑和参数空间中寻找解决方案，这一过程困难且耗时。需要自动化工具来加速从功能需求到可实施机制的转化。

Method: GenAI-Net采用生成式AI框架，结合一个提出反应的代理和基于用户指定目标的模拟评估系统。通过这种耦合方式自动探索化学反应网络的设计空间。

Result: 该框架能够高效生成新颖且拓扑多样的解决方案，适用于多种设计任务，包括剂量响应、复杂逻辑门、分类器、振荡器，以及在确定性和随机设置下的鲁棒完美适应（包括噪声降低）。

Conclusion: GenAI-Net通过将功能规格转化为候选电路家族和可重用模块，为可编程生物分子电路设计提供了通用途径，加速了从期望功能到可实施机制的转化过程。

Abstract: Biomolecular networks underpin emerging technologies in synthetic biology-from robust biomanufacturing and metabolic engineering to smart therapeutics and cell-based diagnostics-and also provide a mechanistic language for understanding complex dynamics in natural and ecological systems. Yet designing chemical reaction networks (CRNs) that implement a desired dynamical function remains largely manual: while a proposed network can be checked by simulation, the reverse problem of discovering a network from a behavioral specification is difficult, requiring substantial human insight to navigate a vast space of topologies and kinetic parameters with nonlinear and possibly stochastic dynamics. Here we introduce GenAI-Net, a generative AI framework that automates CRN design by coupling an agent that proposes reactions to simulation-based evaluation defined by a user-specified objective. GenAI-Net efficiently produces novel, topologically diverse solutions across multiple design tasks, including dose responses, complex logic gates, classifiers, oscillators, and robust perfect adaptation in deterministic and stochastic settings (including noise reduction). By turning specifications into families of circuit candidates and reusable motifs, GenAI-Net provides a general route to programmable biomolecular circuit design and accelerates the translation from desired function to implementable mechanisms.

</details>


### [4] [Quantitative cancer-immunity cycle modeling to optimize bevacizumab and atezolizumab combination therapy for advanced renal cell carcinoma](https://arxiv.org/abs/2601.17669)
*Lei Du,Chenghang Li,Jinzhi Lei*

Main category: q-bio.QM

TL;DR: 开发了定量癌症-免疫循环（QCIC）模型，结合微分方程和随机建模，用于预测晚期肾细胞癌的肿瘤演化，优化贝伐珠单抗和阿特珠单抗联合治疗方案。


<details>
  <summary>Details</summary>
Motivation: 晚期肾细胞癌发病率上升，传统放化疗效果有限且副作用严重，联合免疫疗法虽有前景但个体异质性导致治疗策略优化困难。

Method: 构建QCIC模型，整合常微分方程和随机建模，结合定量系统药理学原理和生物学机制知识，使用临床免疫组化数据校准参数，耦合药代动力学方程，定义肿瘤反应指数（TRI）作为疗效量化指标。

Result: 通过系统分析确定了贝伐珠单抗和阿特珠单抗联合治疗的最佳方案，识别了具有临床预测价值的肿瘤生物标志物。

Conclusion: 该研究为晚期肾细胞癌的精准医疗提供了理论框架和方法学支持。

Abstract: The incidence of advanced renal cell carcinoma(RCC) has been rising, presenting significant challenges due to the limited efficacy and severe side effects of traditional radiotherapy and chemotherapy. While combination immunotherapies show promise, optimizing treatment strategies remains difficult due to individual heterogeneity. To address this, we developed a Quantitative Cancer-Immunity Cycle (QCIC) model that integrates ordinary differential equations with stochastic modelling to quantitatively characterize and predict tumor evolution in patients with advanced RCC. By systematically integrating quantitative systems pharmacology principles with biological mechanistic knowledge, we constructed a virtual patient cohort and calibrated the model parameters using clinical immunohistochemistry data to ensure biological validity. To enhance predictive performance, we coupled the model with pharmacokinetic equations and defined the Tumor Response Index (TRI) as a quantitative metric of efficacy. Systematic analysis of the QCIC model allowed us to determine an optimal treatment regimen for the combination of bevacizumab and atezolizumab and identify tumor biomarkers with clinical predictive value. This study provides a theoretical framework and methodological support for precision medicine in the treatment of advanced RCC.

</details>


### [5] [Point transformer for protein structural heterogeneity analysis using CryoEM](https://arxiv.org/abs/2601.18713)
*Muyuan Chen,Muchen Li,Renjie Liao*

Main category: q-bio.QM

TL;DR: 使用Point Transformer自注意力网络改进冷冻电镜数据的异质性分析，以更可解释的方式表征复杂蛋白质系统的动力学


<details>
  <summary>Details</summary>
Motivation: 蛋白质的结构动力学对其结构-功能关系至关重要。冷冻电镜提供了蛋白质在不同组成和构象状态下的快照，但具有多自由度的蛋白质系统仍难以解析和解释不同的动力学模式。

Method: 实现Point Transformer，这是一种为点云分析设计的自注意力网络，用于改进冷冻电镜数据的异质性分析。

Result: 能够提高冷冻电镜数据异质性分析的性能，并以更人类可解释的方式表征高度复杂蛋白质系统的动力学。

Conclusion: Point Transformer方法能够更好地解析复杂蛋白质系统的结构异质性，提供更直观的动力学表征，有助于理解蛋白质的结构-功能关系。

Abstract: Structural dynamics of macromolecules is critical to their structural-function relationship. Cryogenic electron microscopy (CryoEM) provides snapshots of vitrified protein at different compositional and conformational states, and the structural heterogeneity of proteins can be characterized through computational analysis of the images. For protein systems with multiple degrees of freedom, it is still challenging to disentangle and interpret the different modes of dynamics. Here, by implementing Point Transformer, a self-attention network designed for point cloud analysis, we are able to improve the performance of heterogeneity analysis on CryoEM data, and characterize the dynamics of highly complex protein systems in a more human-interpretable way.

</details>


<div id='cs.CV'></div>

# cs.CV [[Back]](#toc)

### [6] [Semi-Supervised Domain Adaptation with Latent Diffusion for Pathology Image Classification](https://arxiv.org/abs/2601.17228)
*Tengyue Zhang,Ruiwen Ding,Luoting Zhuang,Yuxiao Wu,Erika F. Rodriguez,William Hsu*

Main category: cs.CV

TL;DR: 提出基于潜在扩散模型的半监督域自适应框架，通过生成保留源域组织结构且具有目标域外观特征的合成图像，改善计算病理学中的域泛化问题。


<details>
  <summary>Details</summary>
Motivation: 计算病理学中的深度学习模型常因域偏移而无法在不同队列和机构间泛化。现有方法要么无法利用目标域的无标签数据，要么依赖可能扭曲组织结构的图像翻译方法。

Method: 提出半监督域自适应框架，使用在源域和目标域无标签数据上训练的潜在扩散模型，通过条件化基础模型特征、队列身份和组织制备方法，生成保留组织结构的目标感知合成图像，用于训练下游分类器。

Result: 在肺腺癌预后预测任务中，该方法显著提升了目标域测试集性能，加权F1分数从0.611提升到0.706，宏观F1分数从0.641提升到0.716，且未降低源域性能。

Conclusion: 目标感知的扩散模型合成数据增强为改善计算病理学中的域泛化提供了一种有前景且有效的方法。

Abstract: Deep learning models in computational pathology often fail to generalize across cohorts and institutions due to domain shift. Existing approaches either fail to leverage unlabeled data from the target domain or rely on image-to-image translation, which can distort tissue structures and compromise model accuracy. In this work, we propose a semi-supervised domain adaptation (SSDA) framework that utilizes a latent diffusion model trained on unlabeled data from both the source and target domains to generate morphology-preserving and target-aware synthetic images. By conditioning the diffusion model on foundation model features, cohort identity, and tissue preparation method, we preserve tissue structure in the source domain while introducing target-domain appearance characteristics. The target-aware synthetic images, combined with real, labeled images from the source cohort, are subsequently used to train a downstream classifier, which is then tested on the target cohort. The effectiveness of the proposed SSDA framework is demonstrated on the task of lung adenocarcinoma prognostication. The proposed augmentation yielded substantially better performance on the held-out test set from the target cohort, without degrading source-cohort performance. The approach improved the weighted F1 score on the target-cohort held-out test set from 0.611 to 0.706 and the macro F1 score from 0.641 to 0.716. Our results demonstrate that target-aware diffusion-based synthetic data augmentation provides a promising and effective approach for improving domain generalization in computational pathology.

</details>


### [7] [BMDS-Net: A Bayesian Multi-Modal Deep Supervision Network for Robust Brain Tumor Segmentation](https://arxiv.org/abs/2601.17504)
*Yan Zhou,Zhen Huang,Yingqiu Li,Yue Ouyang,Suncheng Xiang,Zehua Wang*

Main category: cs.CV

TL;DR: BMDS-Net是一个专注于临床稳健性和可信度的脑肿瘤分割框架，通过零初始化多模态上下文融合和残差门控深度解码器监督构建稳健主干，并采用内存高效的贝叶斯微调策略提供体素级不确定性图，在缺失模态场景下表现优异。


<details>
  <summary>Details</summary>
Motivation: 当前基于Transformer的脑肿瘤分割模型（如Swin UNETR）虽然在基准测试中表现优异，但在临床实践中存在两个关键问题：对缺失模态的敏感性（临床常见情况）和缺乏置信度校准。单纯追求理想化数据上的更高Dice分数无法满足真实医疗部署的安全要求。

Method: 1. 构建稳健确定性主干：集成零初始化多模态上下文融合（MMCF）模块和残差门控深度解码器监督（DDS）机制，实现稳定特征学习和精确边界划分；2. 引入内存高效的贝叶斯微调策略：将网络转换为概率预测器，提供体素级不确定性图；3. 在BraTS 2021数据集上进行全面实验验证。

Result: BMDS-Net不仅保持了竞争力的准确性，更重要的是在基线模型失败的缺失模态场景下表现出卓越的稳定性，显著减少了Hausdorff距离，并提供不确定性图帮助临床医生识别潜在错误。

Conclusion: BMDS-Net是一个统一框架，优先考虑临床稳健性和可信度而非简单的指标最大化，通过结合稳健主干和贝叶斯不确定性估计，为真实世界医疗部署提供了更安全可靠的分割解决方案。

Abstract: Accurate brain tumor segmentation from multi-modal magnetic resonance imaging (MRI) is a prerequisite for precise radiotherapy planning and surgical navigation. While recent Transformer-based models such as Swin UNETR have achieved impressive benchmark performance, their clinical utility is often compromised by two critical issues: sensitivity to missing modalities (common in clinical practice) and a lack of confidence calibration. Merely chasing higher Dice scores on idealized data fails to meet the safety requirements of real-world medical deployment. In this work, we propose BMDS-Net, a unified framework that prioritizes clinical robustness and trustworthiness over simple metric maximization. Our contribution is three-fold. First, we construct a robust deterministic backbone by integrating a Zero-Init Multimodal Contextual Fusion (MMCF) module and a Residual-Gated Deep Decoder Supervision (DDS) mechanism, enabling stable feature learning and precise boundary delineation with significantly reduced Hausdorff Distance, even under modality corruption. Second, and most importantly, we introduce a memory-efficient Bayesian fine-tuning strategy that transforms the network into a probabilistic predictor, providing voxel-wise uncertainty maps to highlight potential errors for clinicians. Third, comprehensive experiments on the BraTS 2021 dataset demonstrate that BMDS-Net not only maintains competitive accuracy but, more importantly, exhibits superior stability in missing-modality scenarios where baseline models fail. The source code is publicly available at https://github.com/RyanZhou168/BMDS-Net.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [8] [TwinPurify: Purifying gene expression data to reveal tumor-intrinsic transcriptional programs via self-supervised learning](https://arxiv.org/abs/2601.18640)
*Zhiwei Zheng,Kevin Bryson*

Main category: cs.LG

TL;DR: TwinPurify是一个基于Barlow Twins自监督学习的表示学习框架，用于从批量转录组数据中分离肿瘤特异性信号，无需外部参考，通过利用同一队列中的相邻正常组织作为"背景"指导来学习连续的高维肿瘤嵌入。


<details>
  <summary>Details</summary>
Motivation: 大规模患者队列研究仍依赖批量转录组数据，但肿瘤纯度变化会掩盖肿瘤内在转录信号并限制下游发现。现有的去卷积方法在合成混合物上表现良好，但无法推广到真实患者队列，因为未建模的生物和技术变异。

Method: TwinPurify采用Barlow Twins自监督学习目标，利用同一队列中的相邻正常组织作为"背景"指导，学习连续的高维肿瘤嵌入，而不是将批量混合物解析为离散的细胞类型分数。该方法无需依赖任何外部参考。

Result: 在多个大型癌症队列的RNA-seq和微阵列平台上，TwinPurify在恢复肿瘤内在和免疫信号方面优于传统表示学习方法（如自编码器）。纯化的嵌入改善了分子亚型和分级分类，增强了生存模型一致性，并揭示了比原始批量谱更有生物学意义的通路活性。

Conclusion: TwinPurify通过提供可转移的批量转录组去污染框架，扩展了现有临床数据集在分子发现中的实用性，代表了与去卷积范式的根本性转变。

Abstract: Advances in single-cell and spatial transcriptomic technologies have transformed tumor ecosystem profiling at cellular resolution. However, large scale studies on patient cohorts continue to rely on bulk transcriptomic data, where variation in tumor purity obscures tumor-intrinsic transcriptional signals and constrains downstream discovery. Many deconvolution methods report strong performance on synthetic bulk mixtures but fail to generalize to real patient cohorts because of unmodeled biological and technical variation.
  Here, we introduce TwinPurify, a representation learning framework that adapts the Barlow Twins self-supervised objective, representing a fundamental departure from the deconvolution paradigm. Rather than resolving the bulk mixture into discrete cell-type fractions, TwinPurify instead learns continuous, high-dimensional tumor embeddings by leveraging adjacent-normal profiles within the same cohort as "background" guidance, enabling the disentanglement of tumor-specific signals without relying on any external reference.
  Benchmarked against multiple large cancer cohorts across RNA-seq and microarray platforms, TwinPurify outperforms conventional representation learning baselines like auto-encoders in recovering tumor-intrinsic and immune signals. The purified embeddings improve molecular subtype and grade classification, enhance survival model concordance, and uncover biologically meaningful pathway activities compared to raw bulk profiles. By providing a transferable framework for decontaminating bulk transcriptomics, TwinPurify extends the utility of existing clinical datasets for molecular discovery.

</details>
